NasdaqGS - Delayed Quote USD
Crinetics Pharmaceuticals, Inc. (CRNX)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 5:18 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 327,106 | 19 |
| Sales | 329,874 | 21 |
| Net Shares Purchased (Sold) | -2,768 | 40 |
| Total Insider Shares Held | 1.49M | -- |
| % Net Shares Purchased (Sold) | -0.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PIZZUTI DANA J Officer | Conversion of Exercise of derivative security at price 16.89 per share. | Direct | 242,794 | Oct 3, 2024 |
| PIZZUTI DANA J Officer | Sale at price 54.63 per share. | Direct | 785,306 | Oct 3, 2024 |
| WILSON MARC Chief Financial Officer | Conversion of Exercise of derivative security at price 15.29 per share. | Direct | 382,250 | Sep 26, 2024 |
| WILSON MARC Chief Financial Officer | Sale at price 51.11 per share. | Direct | 1,277,750 | Sep 26, 2024 |
| BETZ STEPHEN F Officer | Sale at price 51.50 per share. | Direct | 53,302 | Sep 10, 2024 |
| BETZ STEPHEN F Officer | Sale at price 53.19 per share. | Direct | 159,570 | Aug 26, 2024 |
| BETZ STEPHEN F Officer | Sale at price 47.68 per share. | Direct | 143,040 | Aug 12, 2024 |
| WILSON MARC Chief Financial Officer | Conversion of Exercise of derivative security at price 9.28 per share. | Direct | 176,840 | Jul 25, 2024 |
| WILSON MARC Chief Financial Officer | Sale at price 53.88 per share. | Direct | 1,026,737 | Jul 25, 2024 |
| BETZ STEPHEN F Officer | Sale at price 53.43 per share. | Direct | 160,290 | Jul 25, 2024 |
| WILSON MARC Chief Financial Officer | Conversion of Exercise of derivative security at price 20.02 per share. | Direct | 500,500 | Jul 15, 2024 |
| KNIGHT JEFF E Chief Operating Officer | Conversion of Exercise of derivative security at price 19.64 - 23.98 per share. | Direct | 589,116 | Jul 15, 2024 |
| WILSON MARC Chief Financial Officer | Sale at price 55.00 per share. | Direct | 1,375,000 | Jul 15, 2024 |
| KNIGHT JEFF E Chief Operating Officer | Sale at price 55.00 per share. | Direct | 1,485,000 | Jul 15, 2024 |
| BETZ STEPHEN F Officer | Sale at price 48.55 per share. | Direct | 145,650 | Jul 10, 2024 |
| HASSARD JAMES Officer | Conversion of Exercise of derivative security at price 19.73 per share. | Direct | 295,950 | Jul 5, 2024 |
| HASSARD JAMES Officer | Sale at price 44.08 per share. | Direct | 661,200 | Jul 5, 2024 |
| PIZZUTI DANA J Officer | Conversion of Exercise of derivative security at price 16.89 per share. | Direct | 242,794 | Jul 3, 2024 |
| PIZZUTI DANA J Officer | Sale at price 44.87 per share. | Direct | 645,006 | Jul 3, 2024 |
| WILSON MARC Chief Financial Officer | Conversion of Exercise of derivative security at price 9.28 per share. | Direct | 298,157 | Jun 28, 2024 |
| WILSON MARC Chief Financial Officer | Sale at price 43.61 per share. | Direct | 1,401,146 | Jun 28, 2024 |
| KNIGHT JEFF E Chief Operating Officer | Sale at price 44.38 per share. | Direct | 42,427 | Jun 26, 2024 |
| BETZ STEPHEN F Officer | Sale at price 45.37 per share. | Direct | 136,110 | Jun 25, 2024 |
| PIZZUTI DANA J Officer | Conversion of Exercise of derivative security at price 19.73 per share. | Direct | 187,435 | Jun 24, 2024 |
| PIZZUTI DANA J Officer | Sale at price 45.73 per share. | Direct | 434,435 | Jun 24, 2024 |
| HASSARD JAMES Officer | Conversion of Exercise of derivative security at price 19.73 per share. | Direct | 295,950 | Jun 21, 2024 |
| HASSARD JAMES Officer | Sale at price 44.66 per share. | Direct | 669,900 | Jun 21, 2024 |
| BETZ STEPHEN F Officer | Sale at price 43.86 per share. | Direct | 131,580 | Jun 10, 2024 |
| WIERENGA WENDELL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| BEDROSIAN CAMILLE L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| VIVALDI COELHO ROGERIO Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| OKEY STEPHANIE S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| NICHOLS WESTON A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| FUST MATTHEW K. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| DEARDORF CAREN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| BETZ STEPHEN F Officer | Sale at price 47.49 per share. | Direct | 142,470 | May 28, 2024 |
| BETZ STEPHEN F Officer | Sale at price 49.43 per share. | Direct | 148,290 | May 10, 2024 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Conversion of Exercise of derivative security at price 9.28 per share. | Direct | 997,117 | May 8, 2024 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Sale at price 49.40 per share. | Direct | 5,307,931 | May 8, 2024 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Apr 18, 2024 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Conversion of Exercise of derivative security at price 1.91 per share. | Direct | 38,200 | Apr 15, 2024 |
| PIZZUTI DANA J Officer | Conversion of Exercise of derivative security at price 16.89 per share. | Direct | 242,794 | Apr 15, 2024 |
| PIZZUTI DANA J Officer | Sale at price 44.47 per share. | Direct | 639,256 | Apr 15, 2024 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Conversion of Exercise of derivative security at price 9.28 per share. | Direct | 380,025 | Apr 4, 2024 |
| STRUTHERS RICHARD SCOTT Chief Executive Officer | Sale at price 49.17 per share. | Direct | 2,013,561 | Apr 4, 2024 |
| OKEY STEPHANIE S Director | Conversion of Exercise of derivative security at price 18.29 per share. | Direct | 320,075 | Mar 28, 2024 |
| OKEY STEPHANIE S Director | Sale at price 46.38 per share. | Direct | 811,650 | Mar 28, 2024 |
| KNIGHT JEFF E Chief Operating Officer | Conversion of Exercise of derivative security at price 23.98 per share. | Direct | 719,400 | Mar 22, 2024 |
| KNIGHT JEFF E Chief Operating Officer | Sale at price 44.22 - 45.39 per share. | Direct | 1,433,675 | Mar 22, 2024 |
| FUST MATTHEW K. Director | Conversion of Exercise of derivative security at price 18.29 - 23.24 per share. | Direct | 1,254,975 | Mar 20, 2024 |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
35.57
+0.17%
ACLX Arcellx, Inc.
96.86
+1.67%
JANX Janux Therapeutics, Inc.
50.03
+0.44%
NMRA Neumora Therapeutics, Inc.
16.49
-2.77%
CYTK Cytokinetics, Incorporated
54.97
+0.81%
KYMR Kymera Therapeutics, Inc.
46.41
+0.35%
RVMD Revolution Medicines, Inc.
50.43
+0.86%
PRAX Praxis Precision Medicines, Inc.
73.20
-2.30%
STOK Stoke Therapeutics, Inc.
13.00
-2.03%
BHVN Biohaven Ltd.
52.96
+2.56%